{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:31:49Z","timestamp":1793043109426,"version":"4.5.0"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2023,4,18]]},"abstract":"\n Importance<\/jats:title>\n Skin cancer is the most commonly diagnosed cancer in the US. There are different types of skin cancer varying in disease incidence and severity. Basal and squamous cell carcinomas are the most common types of skin cancer but infrequently lead to death or substantial morbidity. Melanomas represent about 1% of skin cancer and cause the most skin cancer deaths. Melanoma is about 30 times more common in White persons than in Black persons. However, persons with darker skin color are often diagnosed at later stages, when skin cancer is more difficult to treat.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To update its 2016 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a systematic review on the benefits and harms of screening for skin cancer in asymptomatic adolescents and adults.<\/jats:p>\n <\/jats:sec>\n \n Population<\/jats:title>\n Asymptomatic adolescents and adults who do not have a history of premalignant or malignant skin lesions.<\/jats:p>\n <\/jats:sec>\n \n Evidence Assessment<\/jats:title>\n The USPSTF concludes that the evidence is insufficient to determine the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in asymptomatic adolescents and adults.<\/jats:p>\n <\/jats:sec>\n \n Recommendation<\/jats:title>\n The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults. (I statement)<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jama.2023.4342","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T11:56:37Z","timestamp":1681818997000},"page":"1290","source":"Crossref","is-referenced-by-count":115,"title":["Screening for Skin Cancer"],"prefix":"10.1001","volume":"329","author":[{"name":"US Preventive Services Task Force","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol M.","family":"Mangione","sequence":"additional","affiliation":[{"name":"University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Barry","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanda K.","family":"Nicholson","sequence":"additional","affiliation":[{"name":"George Washington University, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Chelmow","sequence":"additional","affiliation":[{"name":"Virginia Commonwealth University, Richmond"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tumaini Rucker","family":"Coker","sequence":"additional","affiliation":[{"name":"University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esa M.","family":"Davis","sequence":"additional","affiliation":[{"name":"University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina E.","family":"Donahue","sequence":"additional","affiliation":[{"name":"University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Roberto","family":"Ja\u00e9n","sequence":"additional","affiliation":[{"name":"University of Texas Health Science Center, San Antonio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Kubik","sequence":"additional","affiliation":[{"name":"George Mason University, Fairfax, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[{"name":"University of Virginia, Charlottesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gbenga","family":"Ogedegbe","sequence":"additional","affiliation":[{"name":"New York University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goutham","family":"Rao","sequence":"additional","affiliation":[{"name":"Case Western Reserve University, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Ruiz","sequence":"additional","affiliation":[{"name":"University of Arizona, Tucson"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Stevermer","sequence":"additional","affiliation":[{"name":"University of Missouri, Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Tsevat","sequence":"additional","affiliation":[{"name":"University of Texas Health Science Center, San Antonio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Millon","family":"Underwood","sequence":"additional","affiliation":[{"name":"University of Wisconsin, Milwaukee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"Wong","sequence":"additional","affiliation":[{"name":"Tufts University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"jus230004r6","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1001\/jamaoncol.2022.0134","article-title":"Differences in thickness-specific incidence and factors associated with cutaneous melanoma in the US from 2010 to 2018.","volume":"8","author":"Chen","year":"2022","journal-title":"JAMA Oncol"},{"issue":"1","key":"jus230004r7","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1186\/s12885-016-2747-6","article-title":"Racial differences in six major subtypes of melanoma: descriptive epidemiology.","volume":"16","author":"Wang","year":"2016","journal-title":"BMC Cancer"},{"issue":"6","key":"jus230004r9","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/j.jaad.2020.07.125","article-title":"The impact of demographics, socioeconomics, and health care access on melanoma outcomes.","volume":"84","author":"Cortez","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"jus230004r12","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jss.2020.02.010","article-title":"Acral lentiginous melanoma: incidence and survival in the United States, 2006-2015, an analysis of the SEER registry.","volume":"251","author":"Huang","year":"2020","journal-title":"J Surg Res"},{"issue":"4","key":"jus230004r13","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1001\/jamadermatol.2022.0139","article-title":"Estimating overdiagnosis of melanoma using trends among black and white patients in the US.","volume":"158","author":"Adamson","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"7","key":"jus230004r14","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1001\/jama.281.7.640","article-title":"Is physician detection associated with thinner melanomas?","volume":"281","author":"Epstein","year":"1999","journal-title":"JAMA"},{"issue":"1","key":"jus230004r15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1001\/archdermatol.2010.414","article-title":"Skin cancer screening by dermatologists, family practitioners, and internists: barriers and facilitating factors.","volume":"147","author":"Oliveria","year":"2011","journal-title":"Arch Dermatol"},{"issue":"11","key":"jus230004r18","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1001\/jama.2018.1623","article-title":"Behavioral counseling to prevent skin cancer: US Preventive Services Task Force recommendation statement.","volume":"319","author":"US Preventive Services Task Force","year":"2018","journal-title":"JAMA"},{"issue":"4","key":"jus230004r19","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1001\/jama.2016.8465","article-title":"Screening for skin cancer: US Preventive Services Task Force recommendation statement.","volume":"316","author":"US Preventive Services Task Force","year":"2016","journal-title":"JAMA"},{"key":"jus230004r20","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2023.3262","article-title":"Skin cancer screening: updated evidence report and systematic review for the US Preventive Services Task Force.","author":"Henrikson","year":"2023","journal-title":"JAMA"},{"issue":"38","key":"jus230004r21","first-page":"629","article-title":"Skin cancer screening in Germany: documenting melanoma incidence and mortality from 2008 to 2013.","volume":"112","author":"Katalinic","year":"2015","journal-title":"Dtsch Arztebl Int"},{"issue":"3","key":"jus230004r22","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10198-017-0888-4","article-title":"The effectiveness of a population-based skin cancer screening program: evidence from Germany.","volume":"19","author":"Kaiser","year":"2018","journal-title":"Eur J Health Econ"},{"issue":"1","key":"jus230004r23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/bjd.20658","article-title":"Are patients benefiting from participation in the German skin cancer screening programme? a large cohort study based on administrative data.","volume":"186","author":"Datzmann","year":"2022","journal-title":"Br J Dermatol"},{"issue":"17","key":"jus230004r24","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003315","article-title":"Association between race\/ethnicity and survival of melanoma patients in the United States over 3 decades: a secondary analysis of SEER data.","volume":"95","author":"Ward-Peterson","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"jus230004r25","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1046\/j.1524-4725.2000.00036.x","article-title":"Deep shave excision of macular melanocytic nevi with the razor blade biopsy technique.","volume":"26","author":"Gambichler","year":"2000","journal-title":"Dermatol Surg"},{"issue":"3","key":"jus230004r26","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/bjd.2019.180.issue-3","article-title":"Psychosocial impact of skin biopsies in the setting of melanoma screening: a cross-sectional survey.","volume":"180","author":"Matthews","year":"2019","journal-title":"Br J Dermatol"},{"key":"jus230004r27","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.pmedr.2018.04.011","article-title":"Psychosocial consequences of skin cancer screening.","volume":"10","author":"Risica","year":"2018","journal-title":"Prev Med Rep"},{"key":"jus230004r8","volume-title":"Screening for Skin Cancer: A Systematic Evidence Review for the US Preventive Services Task Force. Evidence Synthesis No. 225","author":"Henrikson","year":"2022"},{"key":"jus230004r1","unstructured":"Skin cancer. Centers for Disease Control and Prevention. Last reviewed April 18, 2022. Accessed March 2, 2023. https:\/\/www.cdc.gov\/cancer\/skin\/index.htm"},{"key":"jus230004r2","unstructured":"Skin cancer (non-melanoma): introduction. American Society of Clinical Oncology. Published 2022. Accessed March 2, 2023. https:\/\/www.cancer.net\/cancer-types\/skin-cancer-non-melanoma\/introduction"},{"key":"jus230004r3","unstructured":"Key statistics for melanoma skin cancer. American Cancer Society. Last revised January 12, 2023. Accessed March 2, 2023. https:\/\/www.cancer.org\/cancer\/melanoma-skin-cancer\/about\/key-statistics.html"},{"key":"jus230004r4","unstructured":"Surveillance, Epidemiology, and End Results Program. SEER*Explorer: recent trends in SEER age-adjusted incidence rates, 2000-2019. National Cancer Institute. Accessed March 2, 2023. https:\/\/seer.cancer.gov\/statistics-network\/explorer\/"},{"key":"jus230004r5","unstructured":"Skin cancer: incidence rates. American Academy of Dermatology Association. Accessed March 2, 2023. https:\/\/www.aad.org\/media\/stats-skin-cancer"},{"key":"jus230004r10","unstructured":"US Preventive Services Task Force Procedure Manual. US Preventive Services Task Force. Updated August 2022. Accessed March 2, 2023. https:\/\/uspreventiveservicestaskforce.org\/uspstf\/procedure-manual"},{"key":"jus230004r11","unstructured":"Surveillance, Epidemiology, and End Results Program. Cancer Stat Facts: melanoma of the skin. National Cancer Institute. Accessed March 2, 2023. https:\/\/seer.cancer.gov\/statfacts\/html\/melan.html"},{"key":"jus230004r16","unstructured":"The Community Guide. Community Preventive Services Task Force. Accessed March 2, 2023. https:\/\/www.thecommunityguide.org\/"},{"key":"jus230004r17","unstructured":"Melanoma dashboard. Centers for Disease Control and Prevention. Accessed March 2, 2023. http:\/\/ephtracking.cdc.gov\/Applications\/melanomadashboard\/"},{"key":"jus230004r28","unstructured":"Free skin cancer screenings. American Academy of Dermatology Association. Accessed March 2, 2023. https:\/\/www.aad.org\/public\/public-health\/skin-cancer-screenings"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2803797\/jama_mangione_2023_us_230004_1681230413.89853.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T11:56:45Z","timestamp":1681819005000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2803797"}},"subtitle":["US Preventive Services Task Force Recommendation Statement"],"short-title":[],"issued":{"date-parts":[[2023,4,18]]},"references-count":28,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2023,4,18]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2023.4342","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,18]]}}}